Predicting in vivo therapeutic efficacy of bioorthogonally labeled endothelial progenitor cells in hind limb ischemia models via non-invasive fluorescence molecular …

S Lim, HY Yoon, SJ Park, S Song, MK Shim, S Yang… - Biomaterials, 2021 - Elsevier
Human embryonic stem cells-derived endothelial progenitor cells (hEPCs) were utilized as
cell therapeutics for the treatment of ischemic diseases. However, in vivo tracking of hEPCs …
被引用次数：17 相关文章

Predicting in vivo therapeutic efficacy of bioorthogonally labeled endothelial progenitor cells in hind limb ischemia models via non-invasive fluorescence molecular …

S Lim, HY Yoon, SJ Park, S Song, MK Shim, S Yang… - …, 2021 - s-space.snu.ac.kr
Human embryonic stem cells-derived endothelial progenitor cells (hEPCs) were utilized as
cell therapeutics for the treatment of ischemic diseases. However, in vivo tracking of hEPCs …

Predicting in vivo therapeutic efficacy of bioorthogonally labeled endothelial progenitor cells in hind limb ischemia models via non-invasive fluorescence molecular …

S Lim, HY Yoon, SJ Park, S Song, MK Shim… - …, 2021 - scholarworks.bwise.kr
Human embryonic stem cells-derived endothelial progenitor cells (hEPCs) were utilized as
cell therapeutics for the treatment of ischemic diseases. However, in vivo tracking of hEPCs …

Predicting in vivo therapeutic efficacy of bioorthogonally labeled endothelial progenitor cells in hind limb ischemia models via non-invasive fluorescence molecular …

S Lim, HY Yoon, SJ Park, S Song, MK Shim, S Yang… - Biomaterials, 2020 - europepmc.org
Human embryonic stem cells-derived endothelial progenitor cells (hEPCs) were utilized as
cell therapeutics for the treatment of ischemic diseases. However, in vivo tracking of hEPCs …

Predicting in vivo therapeutic efficacy of bioorthogonally labeled endothelial progenitor cells in hind limb ischemia models via non-invasive fluorescence molecular …

S Lim, HY Yoon, SJ Park, S Song, MK Shim… - …, 2021 - pubmed.ncbi.nlm.nih.gov
Human embryonic stem cells-derived endothelial progenitor cells (hEPCs) were utilized as
cell therapeutics for the treatment of ischemic diseases. However, in vivo tracking of hEPCs …

Predicting in vivo therapeutic efficacy of bioorthogonally labeled endothelial progenitor cells in hind limb ischemia models via non-invasive fluorescence molecular …

S Lim, HY Yoon, SJ Park, S Song, MK Shim… - …, 2021 - scholar.korea.ac.kr
Human embryonic stem cells-derived endothelial progenitor cells (hEPCs) were utilized as
cell therapeutics for the treatment of ischemic diseases. However, in vivo tracking of hEPCs …

Predicting in vivo therapeutic efficacy of bioorthogonally labeled endothelial progenitor cells in hind limb ischemia models via non-invasive fluorescence molecular …

S Lim, HY Yoon, SJ Park, S Song, MK Shim, S Yang… - Biomaterials, 2021 - pure.korea.ac.kr
Human embryonic stem cells-derived endothelial progenitor cells (hEPCs) were utilized as
cell therapeutics for the treatment of ischemic diseases. However, in vivo tracking of hEPCs …

Predicting in vivo therapeutic efficacy of bioorthogonally labeled endothelial progenitor cells in hind limb ischemia models via non-invasive fluorescence molecular …

S Lim, HY Yoon, SJ Park, S Song, MK Shim, S Yang… - Biomaterials, 2021 - pure.ewha.ac.kr
Human embryonic stem cells-derived endothelial progenitor cells (hEPCs) were utilized as
cell therapeutics for the treatment of ischemic diseases. However, in vivo tracking of hEPCs …

[引用][C] Predicting in vivo therapeutic efficacy of bioorthogonally labeled endothelial progenitor cells in hind limb ischemia models via non-invasive fluorescence …

S Lim, HY Yoon, SJ Park, S Song, MK Shim, S Yang… - 2021